Literature DB >> 1306727

Oral infection as a reason for febrile episodes in lymphoma patients receiving cytostatic drugs.

P O Laine1, J C Lindqvist, S O Pyrhönen, I M Strand-Pettinen, L M Teerenhovi, J H Meurman.   

Abstract

56 patients receiving chemotherapy for non-Hodgkin lymphoma or Hodgkin's disease with curative intent were monitored for up to one year after initiation of treatment. During chemotherapy (mean duration 5.2 months), 26 of the patients (46%) suffered from 38 febrile episodes. In only 16 instances was an extraoral cause for the septicaemia found. However, severe dental infection, reflected in an elevated radiological index for the jaws, was found more frequently in patients suffering febrile episodes than in those without (P = 0.02). Moderate to severe gingival inflammation was observed during 22 (58%) of episodes. During 71% of the episodes various pathological findings were also recorded in the oral mucosa. No source of infection other than an oral one was found in 42% of the patients. Our results emphasise the importance of oral foci as the possible infection source in patients receiving intensive chemotherapy.

Entities:  

Mesh:

Year:  1992        PMID: 1306727     DOI: 10.1016/0964-1955(92)90036-z

Source DB:  PubMed          Journal:  Eur J Cancer B Oral Oncol        ISSN: 0964-1955


  12 in total

Review 1.  A systematic review of oral fungal infections in patients receiving cancer therapy.

Authors:  Rajesh V Lalla; Marie C Latortue; Catherine H Hong; Anura Ariyawardana; Sandra D'Amato-Palumbo; Dena J Fischer; Andrew Martof; Ourania Nicolatou-Galitis; Lauren L Patton; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-05-08       Impact factor: 3.603

2.  B-Cell deficiency predisposes mice to disseminating anaerobic infections: protection by passive antibody transfer.

Authors:  L Hou; H Sasakj; P Stashenko
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Evaluation of risk factors for oral infection with potential for spread in a 1-year cohort study.

Authors:  Esa Färkkilä; Riina Rautemaa-Richardson; Anniina Färkkilä; Lotta Grönholm; Anneli Lauhio
Journal:  Clin Oral Investig       Date:  2018-06-14       Impact factor: 3.573

4.  Mucositis prevention by improved dental care in acute leukemia patients.

Authors:  Milanko Djuric; Valeria Hillier-Kolarov; Aranka Belic; Ljiljana Jankovic
Journal:  Support Care Cancer       Date:  2005-07-22       Impact factor: 3.603

Review 5.  A systematic review of dental disease in patients undergoing cancer therapy.

Authors:  Catherine H L Hong; Joel J Napeñas; Brian D Hodgson; Monique A Stokman; Vickie Mathers-Stauffer; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-05-07       Impact factor: 3.603

6.  Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study.

Authors:  Judith E Raber-Durlacher; Alexa M G A Laheij; Joel B Epstein; Matthew Epstein; Gerard M Geerligs; Gordon N Wolffe; Nicole M A Blijlevens; J Peter Donnelly
Journal:  Support Care Cancer       Date:  2013-01-04       Impact factor: 3.603

7.  Evaluation of Periodontal Parameters in Patients with Early Stage Chronic Lymphocytic Leukemia.

Authors:  Nives Rinčić; Darko Božić; Goran Rinčić; Petar Gaćina; Darije Plančak
Journal:  Acta Stomatol Croat       Date:  2016-03

8.  Febrile neutropenia and periodontitis: lessons from a case periodontal treatment in the intervals between chemotherapy cycles for leukemia reduced febrile neutropenia.

Authors:  Yoshihiko Soga; Yoshiko Yamasuji; Chieko Kudo; Kaori Matsuura-Yoshimoto; Kokoro Yamabe; Yuko Sugiura; Yoshinobu Maeda; Fumihiko Ishimaru; Mitsune Tanimoto; Fusanori Nishimura; Shogo Takashiba
Journal:  Support Care Cancer       Date:  2008-11-18       Impact factor: 3.603

9.  Association between the point-rating system used for oral health and the prevalence of Gram-negative bacilli in hematological inpatients: A retrospective cohort study.

Authors:  Kunio Yoshizawa; Akinori Moroi; Ran Iguchi; Hiroshi Yokomichi; Shinji Ogihara; Kazuaki Watanabe; Kei Nakajima; Keita Kirito; Koichiro Ueki
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.889

Review 10.  Oral complications in hematopoietic stem cell recipients: the role of inflammation.

Authors:  T M Haverman; J E Raber-Durlacher; W M H Rademacher; S Vokurka; J B Epstein; C Huisman; M D Hazenberg; J J de Soet; J de Lange; F R Rozema
Journal:  Mediators Inflamm       Date:  2014-04-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.